Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
October 14, 2022
Enliven Therapeutics and Imara Announce Merger Agreement
October 13, 2022
New Momentum Magnetic Particle Imaging Scanner has been installed in Los Angeles County: Magnetic Insight
October 13, 2022
Enrollment Completed in Phase 3 PATHFNDR-1 Study Evaluating Oral Paltusotine for the Treatment of Acromegaly
October 13, 2022
CinCor Pharma Announces Oral Presentation of Phase 1 Data for Baxdrostat at the Upcoming 29th International Society of Hypertension 2022 Conference
October 12, 2022
Vor Bio Appoints Eyal C. Attar, M.D. as Chief Medical Officer
October 12, 2022
Vor Bio Demonstrates Potential of Base and Sequential Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment
October 11, 2022
scPharmaceuticals Announces $100 Million Debt Financing Agreement with Oaktree
October 11, 2022
scPharmaceuticals Announces FDA Approval of FUROSCIX® (furosemide injection), the First and Only Self-administered, Subcutaneous Loop Diuretic for the At-home Treatment of Congestion in Chronic Heart Failure
October 6, 2022
Artiva Announces AB-101 Abstract Accepted for Presentation at Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting
October 6, 2022
Innovation Passport Granted for CRN04777 for the Treatment of Congenital Hyperinsulinism
« Previous Page
1
…
4
5
6
7
8
…
17
Next Page »